Maltitol DC Granules are pharmaceutical-grade maltitol granules developed for direct compression applications in oral solid dosage formulation. “DC” refers to Direct Compression, a tablet manufacturing approach in which appropriately engineered excipients and formulation components are blended and compressed without a separate wet-granulation step.
Maltitol is a sugar alcohol also known as d-glucopyranosyl-d-glucitol. It has the molecular formula C₁₂H₂₄O₁₁, molecular weight 344.31 g/mol and CAS Number 585-88-6. The current USP-NF Maltitol monograph specifies 92.0% to 100.5% d-maltitol, calculated on an anhydrous basis.
Maltitol DC Granules provide maltitol in an engineered granulated format intended to support controlled handling, blending and compression characteristics. Direct-compression excipients are commonly engineered to improve important material properties such as flow and compactability, which are critical to consistent tablet manufacture.
Maltitol has been investigated as a pharmaceutical excipient for tablet formulation and compression. Research comparing different physical forms of maltitol evaluated tabletability, compaction behavior, particle properties and stability. The study specifically compared amorphous maltitol with a textured crystalline maltitol excipient identified for direct compression.
This research demonstrates that the physical structure and particle engineering of maltitol can significantly influence its performance during tablet compression.
Maltitol DC Granules can therefore be positioned as an engineered pharmaceutical excipient format where controlled particle characteristics are required for direct compression development.
The exact performance of a finished Maltitol DC Granules grade depends on its particle size, morphology, density, moisture level, compressibility, compactability and manufacturing process. These characteristics should be established from the actual product specification rather than assumed from the term “DC.”
Direct compression is a manufacturing process in which formulation components are blended and compressed directly into tablets. Unlike wet or dry granulation, it does not require a separate granulation stage during tablet manufacture.
For direct compression, excipients need appropriate flow and compaction properties. Particle engineering is therefore an important part of direct-compression excipient development. Scientific reviews describe the relationship between excipient material properties, flow, compactability and direct-compression functionality.
Maltitol DC Granules are designed around this principle by providing a controlled particulate form of maltitol for evaluation in direct-compression formulations.
Maltitol has the molecular formula C₁₂H₂₄O₁₁ and molecular weight 344.31 g/mol. Its CAS Number is 585-88-6. USP identifies the material as d-glucopyranosyl-d-glucitol.
According to the current USP-NF Maltitol monograph, Maltitol contains not less than 92.0% and not more than 100.5% d-maltitol, calculated on the anhydrous basis. It may also contain other sugars, polyhydric alcohols and hexitol anhydrides within the monograph framework.
FCC describes Maltitol as a white crystalline powder that is very soluble in water and slightly soluble in ethanol.
The chemical properties of maltitol provide the foundation of the material, while the DC granulation process is intended to establish suitable physical characteristics for pharmaceutical processing.
Particle engineering is particularly important for direct-compression excipients. Powder flow, particle-size distribution, surface characteristics, density and compaction behavior can influence the consistency of tablet manufacturing.
Maltitol DC Granules can be characterized using parameters such as:
These properties are not universal specifications for every Maltitol DC Granules product. The applicable limits should be established according to the actual manufacturing process and validated product specification.
Flowability is an important consideration in direct compression because formulation materials must move consistently through manufacturing equipment.
Granulated excipients can provide a more controlled particle population than fine powders. For Maltitol DC Granules, flow can be evaluated using bulk density, tapped density, Carr Index, Hausner ratio, angle of repose or other validated methods where appropriate.
Consistent flow can support uniform die filling and help maintain tablet weight consistency. However, actual flow performance depends on the specific granule size distribution, moisture level, particle morphology and formulation composition.
Therefore, numerical flow specifications should only be stated when supported by the actual product Certificate of Analysis.
Compactability and tabletability are central characteristics of a direct-compression excipient.
Research on maltitol has demonstrated that changes in physical state can alter compression behavior and tabletability. The study of amorphous maltitol reported differences in compaction behavior compared with a textured crystalline maltitol grade developed for direct compression.
This highlights why the physical form of maltitol is important when developing Maltitol DC Granules.
Depending on the finished material, formulation scientists may evaluate compression force, tensile strength, tablet hardness, friability, ejection behavior and other compression parameters during formulation development.
These are development characteristics and should not be presented as guaranteed product specifications unless they are supported by the approved product specification.
Maltitol DC Granules may be considered for pharmaceutical formulation development involving:
The exact role of Maltitol DC Granules depends on the formulation composition, concentration, tablet design and manufacturing process.
Maltitol is very soluble in water and slightly soluble in ethanol according to FCC.
This characteristic may be useful in formulation development where a water-soluble polyol excipient is desired. However, the behavior of the finished granules can be influenced by particle size, granule porosity, processing conditions and other formulation components.
For this reason, dissolution, disintegration or wetting performance of Maltitol DC Granules should be evaluated using product-specific testing rather than inferred solely from the solubility of the raw material.
Maltitol DC Granules can be evaluated alongside other formulation components according to the desired tablet characteristics. Formulation developers may adjust the concentration of maltitol, active ingredient, disintegrant, lubricant and other excipients to obtain the required tablet properties.
The suitability of Maltitol DC Granules depends on the desired tablet hardness, friability, disintegration, dissolution, flow and compression characteristics.
Direct compression formulations should be optimized using appropriate formulation-development studies rather than assuming that every maltitol grade will perform identically.
Important quality attributes for Maltitol DC Granules may include:
USP provides the chemical material specification for Maltitol, while physical characteristics of a DC granulated product are dependent on the finished grade and manufacturing process.
Therefore, particle-size limits, density values, flow indices and compression parameters should only be published when supported by the actual product specification or Certificate of Analysis.
Maltitol DC Granules should be produced using controlled particle-engineering and granulation processes appropriate for the intended direct-compression application.
Process considerations may include granulation technology, particle-size classification, drying conditions, moisture control, milling and screening. The objective is to establish consistent granule characteristics that support downstream blending and compression.
Critical material attributes can include particle size, density, moisture, morphology, flowability and compaction behavior. These characteristics should be monitored using suitable analytical and physical testing methods.
Quality control of Maltitol DC Granules should address both the chemical quality of maltitol and the physical characteristics required for direct compression.
The USP-NF Maltitol monograph specifies 92.0%–100.5% d-maltitol on an anhydrous basis.
Finished DC granules may additionally require specifications for particle size, bulk density, tapped density, flowability, moisture, compressibility and other validated parameters.
Because these characteristics depend on the finished product, numerical values should not be assigned without supporting product-specific data.
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |